Amplifon S.p.A.
Amplifon S.p.A. engages in the distribution of hearing solutions and the fitting of customized products that helps people to rediscover various emotions of sound in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company operates Ampli-care, a platform to deliver audiological care experience; and Amplifon App to manage the device functions in real-time directly from smart… Read more
Amplifon S.p.A. (0N61) - Total Liabilities
Latest total liabilities as of September 2021: €2.49 Billion EUR
Based on the latest financial reports, Amplifon S.p.A. (0N61) has total liabilities worth €2.49 Billion EUR as of September 2021.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Amplifon S.p.A. - Total Liabilities Trend (2020–2020)
This chart illustrates how Amplifon S.p.A.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Amplifon S.p.A. Competitors by Total Liabilities
The table below lists competitors of Amplifon S.p.A. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Integrated Cannabis Company Inc
PINK:CRPGF
|
USA | $174.81 Billion |
|
Eyebright Medical Technology Beijing Co Ltd
SHG:688050
|
China | CN¥894.96 Million |
|
Bumi Resources Minerals Tbk
JK:BRMS
|
Indonesia | Rp185.57 Million |
|
ARB Corporation Ltd
AU:ARB
|
Australia | AU$134.90 Million |
|
TheRealReal Inc
NASDAQ:REAL
|
USA | $824.55 Million |
|
China Sports Industry Group Co Ltd
SHG:600158
|
China | CN¥2.47 Billion |
|
Galapagos NV
PINK:GLPGF
|
USA | $1.25 Billion |
Liability Composition Analysis (2020–2020)
This chart breaks down Amplifon S.p.A.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.03 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.98 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.75 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Amplifon S.p.A.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Amplifon S.p.A. (2020–2020)
The table below shows the annual total liabilities of Amplifon S.p.A. from 2020 to 2020.
| Year | Total Liabilities | Change |
|---|---|---|
| 2020-12-31 | €2.43 Billion | -- |